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Abstract The human essential splicing factor U2AF (U2 aux-
iliary factor) consists of 35 and 65 kDa subunits which form a
highly stable heterodimer in solution. Copuri¢cation of the re-
combinant U2AF35 RNA recognition motif (U2AF35 RRM)
and full-length U2AF65 yields a soluble and functionally active
minimal U2AF heterodimer. Recombinant U2AF35 RRM pro-
tein free and in complex with three di¡erent regions of U2AF65
was characterized by nuclear magnetic resonance spectroscopy.
We found that the recombinant U2AF35 RRM is unstructured
in solution but its tertiary structure is induced upon binding to
U2AF65. This interaction is mediated by the N-terminal pro-
line-rich region of U2AF65 and does not involve the U2AF65
RRMs. - 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In eukaryotic cells, the intervening non-coding sequences
(introns) have to be removed from the mRNA precursors.
This process, called splicing, is initiated with the recognition
of intron de¢ning sequences by the splicing machinery. The
U2 auxiliary factor (U2AF) plays a critical role in the selec-
tion of the intron 3P-splice site, which is composed of a poly-
pyrimidine tract and an AG dinucleotide. U2AF is a hetero-
dimer and consists of a large (65 kDa) and a small (35 kDa)
subunit in humans [1]. The large subunit (U2AF65) contains
an N-terminal arginine/serine (RS)-rich domain, a proline-rich
region (P) and three RNA recognition motifs (RRM) (Fig. 1).
The primary structure of the small subunit (U2AF35) com-
prises four domains (Fig. 1): a central RRM that is £anked by
two CCCH zinc-binding domains (Zn) and a C-terminal RS
domain.
Both subunits interact with the pre-mRNA. U2AF65 spe-
ci¢cally recognizes the polypyrimidine tract via its RRMs [2],
whereas U2AF35 contacts the conserved AG [3^5]. Due to the
weak homology between the U2AF35 RRM and classical
RRM-type RNA-binding domains, the function of the
U2AF35 RRM remained unclear until recently. In a previous
study, it was shown that the U2AF35 RRM is su⁄cient to
activate splicing of the mouse immunoglobulin M pre-mRNA
[6]. This activity depends on the ability of the U2AF35 RRM
to bind both U2AF65 and the pre-mRNA.
Recently, the crystal structure of a core U2AF heterodimer,
comprising the U2AF35 RRM bound to the U2AF65 P-rich
region, was described showing the structural basis for the
formation of a minimal U2AF65/35 heterodimer [7]. In an
attempt to characterize the U2AF heterodimer interaction in
solution, we cloned, overexpressed and puri¢ed several com-
plexes between the U2AF35 RRM and various regions of
U2AF65. We used nuclear magnetic resonance (NMR) to
examine conformational changes that occur in U2AF35
RRM upon U2AF65 binding. Our data show that the re-
combinant U2AF35 RRM alone is largely unstructured in
solution, but adopts a tertiary structure upon binding to a
U2AF65 fragment which contains the U2AF65 RRM1 in ad-
dition to the P-rich region.
2. Materials and methods
2.1. Cloning
U2AF65(1^475) cloning was previously described [6]. DNA encod-
ing U2AF35(1^240), U2AF35(1^187), U2AF35(1^180), U2AF35(38^
152), U2AF65(88^237), U2AF65(98^237) and U2AF65(88^342) was
PCR ampli¢ed from the full-length cDNA of the proteins with speci¢c
primers. All 5P-sense primers include an NcoI restriction site which
adds an extra methionine to the N-terminus of the expressed protein
products. All 3P-reverse primers contain a KpnI site and a stop codon.
Digested PCR fragments were inserted into pET-based expression
vectors as summarized in Table 1. Plasmids (pACYCT7) for coex-
pression experiments are based on standard pACYC177 (Biolabs)
low copy number plasmids with transferred T7 expression cassette
from pET vectors (Novagen) (G. Stier, unpublished results).
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Fig. 1. U2AF domains. Schematic depiction of protein constructs
expressed. Abbreviations are explained in text.
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2.2. Expression and puri¢cation
U2AF35 FL (full-length), vRS1 (deleted RS domain 1), vRS2 and
RRM were either expressed separately with an N-terminal six-histi-
dine (N-His) tag or coexpressed with untagged U2AF65 FL (Table 1,
Fig. 1). Untagged U2AF65 vP-RRM1 (linker domain missing the
P-rich region) was coexpressed with N-His-tagged U2AF35 RRM.
Untagged U2AF65FL, N-His-tagged U2AF65 P-RRM1 and P-
RRM1+2 proteins were expressed separately.
Plasmids were transfected into Escherichia coli BL21(DE3).
BL21(DE3) pLysS was used for the expression of U2AF35 proteins.
Transformed cells were plated onto Luria^Bertani (LB) agarose plates
containing the required antibiotics (25 Wg/ml kanamycin and/or
100 Wg/ml ampicillin) and incubated over night at 37‡C. For
U2AF35 constructs, large pLysS colonies were selected and restreaked
on fresh LB agarose plate containing 25 Wg/ml kanamycin and 50 Wg/
ml chloramphenicol. Single colonies were picked and grown overnight
at 37‡C in liquid medium containing the required antibiotics. The
preculture was then diluted 50 times in fresh medium at 37‡C. Unla-
beled and 15N-labeled proteins were produced using LB, and standard
M9 medium with 15N-NH4Cl as sole nitrogen source [8], respectively.
The cells were induced with 1 mM isopropyl L-D-thiogalactopyrano-
side (IPTG) at OD600 nm of 0.7^0.8. U2AF65 FL, P-RRM1 and
P-RRM1+2 domains were expressed at 37‡C for 3 h, all U2AF35
domains (including those coexpressed with U2AF65 FL or vP-
RRM1) were expressed at 18‡C for 16 h.
Cells grown in 1 l of culture were harvested by centrifugation,
resuspended in lysis bu¡er (50 mM Tris^HCl, 0.2^0.7 M NaCl,
5 mM L-mercaptoethanol, 10% glycerol, 0.1% Triton, 0.1 mg/ml ly-
sozyme, 1 mM Pefabloc, pH 7.5), disrupted by sonication and centri-
fuged for 1 h at 4‡C at 100 000Ug.
All soluble recombinant proteins and complexes were puri¢ed by
a⁄nity chromatography (Ni-NTA agarose, Qiagen) followed by a gel
¢ltration (Superdex 75 or 200 16/60, Pharmacia). Ni-NTA columns
were equilibrated in 50 mM Tris^HCl, 200 mM NaCl, 5 mM L-mer-
captoethanol and 20 mM imidazole (pH 8), and bound proteins were
eluted by increasing the concentration of imidazole to 300 mM. Gel
¢ltration runs were performed in 20 mM sodium phosphate, 100 mM
NaCl, 1 mM dithiothreitol and 0.02% NaN3 (pH 6), at 1 ml/min £ow
rate.
For U2AF65 P-RRM1 and P-RRM1+2 proteins, the N-His tag
was removed after the ¢rst Ni-NTA column using recombinant histi-
dine-tagged tobacco etchvirus (TEV) protease, leaving two additional
residues (glycine^alanine) at the N-terminus of the protein prior to the
methionine. A second Ni-NTA column eliminates both the protease
and the uncleaved proteins.
U2AF35 RRM expression and puri¢cation yieldedV5 mg andV1
mg of protein from 1 l LB and minimal media, respectively. The
expression yields for the di¡erent U2AF65 domains are about twice
more. To obtain U2AF65 P-RRM1/U2AF35 RRM and U2AF65
P-RRM1+2/U2AF35 RRM complexes, the individual proteins were
mixed in equimolar ratio, as judged from the Coomassie staining of
the pure proteins on SDS^polyacrylamide gel electrophoresis (Fig.
2A). Complexes formed were further puri¢ed using gel ¢ltration
(Fig. 2B).
Protein concentrations, determined by absorbance measurement at
280 nm using theoretical extinction coe⁄cients, range from 0.1 to
0.5 mM. NMR spectra were measured in a 20 mM sodium phosphate
(pH 6.0^6.8) bu¡er in H2O/D2O 9:1, containing 50 mM NaCl, 1 mM
dithiothreitol and 0.02% NaN3.
2.3. NMR spectroscopy
NMR spectra were collected on a Bruker DRX600 spectrometer at
295 or 303 K. Two dimensional 1H,15N HSQC (heteronuclear single
quantum correlation) [9,10] or TROSY (transverse relaxation-opti-
mized spectroscopy) [11,12] experiments were recorded on the free
15N-labeled U2AF35 RRM, and on the U2AF65 P-RRM1/U2AF35
RRM and U2AF65 P-RRM1+2/U2AF35 RRM complexes, which
were 15N-labeled either for the U2AF35 or the U2AF65 subunit.
3. Results and discussion
3.1. The U2AF35 RRM domain is expressed soluble
We designed and cloned four di¡erent U2AF35 proteins
fragments: the FL protein, two constructs lacking the C-ter-
minal RS domain (vRS1 and vRS2) and the RRM alone. All
U2AF35 proteins were toxic when overexpressed in E. coli, as
indicated by a slow growth rate of transformed BL21(DE3) in
the liquid culture. Toxicity was reduced when using a
BL21(DE3) pLysS strain. After cell lysis, U2AF35 FL,
vRS1 and vRS2 were localized in inclusion bodies. Only
U2AF35 RRM was expressed soluble when bacteria were
grown at a temperature below 25‡C. The solubility properties
of the U2AF35 constructs were not improved upon coexpres-
sion of the U2AF35 FL. Presumably, this results from the
instability of expression plasmids even when using a two-plas-
mid coexpression system with plasmids of di¡erent origin and
antibiotic resistance (see Table 1), as has been previously ob-
served [13].
3.2. The free U2AF35 RRM is unstructured in solution
The soluble 15N-labeled U2AF35 RRM was puri¢ed using
Ni-NTA a⁄nity chromatography followed by gel ¢ltration.
The gel ¢ltration pro¢le exhibits a single symmetrical peak
with an elution volume corresponding to a V16 kDa protein
(Fig. 2B). While the protein appears to be monomeric this
unexpected elution volume is not indicative of a globular pro-
tein. We therefore used NMR spectroscopy to determine
whether the recombinant protein is properly folded in solu-
tion. The chemical shift dispersion and line widths in 1H and
15N NMR spectra allow to distinguish whether a protein is
Table 1
Cloning of U2AF65/U2AF35 domains
Domain name Residue range MW (kDa) Source vector Tag Selection
U2AF35
FL 1^240 27.9 pET9-d N-His kanamycin
pACYCT7 ^ kanamycin
vRS1 1^187 21.7 pET24-d N-His-TEV kanamycin
pACYCT7 ^ kanamycin
vRS2 1^180 20.7 pET9-d N-His kanamycin
pACYCT7 ^ kanamycin
RRM 38^152 13.3 pET9-d N-His kanamycin
pACYCT7 ^ kanamycin
pET24-d N-His-GST-TEV kanamycin
U2AF65
FL 1^475 53.5 pET21-d(+) ^ ampicillin
vP-RRM1 98^237 15.3 pET21-d(+) ^ ampicillin
P-RRM1 88^237 16.6 pET24-d N-His-TEV kanamycin
P-RRM1+2 88^342 27.7 pET24-d N-His-TEV kanamycin
In all pET24-d derivatives, a sequence coding for a tobacco etchvirus (TEV) protease cleavage site is localized after the tag.
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completely unfolded (i.e. adopting a random coil conforma-
tion), misfolded (or molten-globule like) or folded [14]. Fig.
3A shows the 1H,15N HSQC spectrum of the 15N-labeled
U2AF35 RRM. The small chemical shift dispersion clearly
indicates that the protein adopts a random coil conformation
and is unstructured in aqueous solution.
These ¢ndings also show that the soluble expression of the
U2AF35 RRM does not imply that the protein adopts a ter-
tiary structure. Note, that the U2AF35 RRM protein ex-
pressed as a fusion with a glutathione S-transferase (GST)
shows the same behavior based on a 1H,15N HSQC spectrum
of the free U2AF35 RRM obtained after GST proteolytic
cleavage. Thus, the presence of the GST carrier protein during
expression is not able to induce a structured protein. Similar
observations have been previously described in the literature
[15,16]. The expression result most likely re£ects the intrinsic
propensity of the unbound protein to be unstructured yet not
prone to aggregation.
3.3. U2AF35 RRM complex with U2AF65 FL
The soluble U2AF35 RRM was used to prepare a recombi-
nant heterodimeric complex with U2AF65 FL [6]. Brie£y, the
His-tagged U2AF35 RRM was immobilized on a Ni-NTA
column, and the resin was incubated with the clear lysate of
E. coli cells expressing untagged U2AF65 FL. After extensive
washing of the column, the bound U2AF65 FL/U2AF35
RRM complex was eluted with imidazole and puri¢ed on a
Superdex 200 gel ¢ltration column. It has been recently
shown, that this recombinant heterodimeric U2AF complex
is fully active in in vitro splicing assays. Indeed, U2AF65 FL/
U2AF35 RRM restores splicing in U2AF-depleted HeLa nu-
clear extract [6]. This functional activity suggests that within
the U2AF heterodimer the U2AF35 RRM adopts a native
conformation, which is induced upon binding to U2AF65 in
vitro.
However, the elution volume of the complex during gel
¢ltration shows an apparent molecular weight (MW) above
400 kDa. Furthermore, a 1H,15N HSQC spectrum recorded
on a 0.1 mM sample of a 15N-labeled U2AF65 FL/unlabeled
U2AF35 RRM complex (data not shown) is consistent with
the high MW of an aggregated state since most of the back-
bone resonances of U2AF35 RRM show severe line-broad-
ening or are not observable. It is conceivable that at the lower
concentration used for the in vitro splicing assays a fraction of
the complex is not aggregated and thus confers the functional
activity. In contrast, the high concentrations used for gel ¢l-
tration and NMR might be above the concentration limit for
aggregation of the U2AF heterodimer.
3.4. U2AF35 RRM complexes with smaller regions of U2AF65
The U2AF35 interacting region of U2AF65 has been pre-
viously mapped to the P-rich fragment spanning residues K90
to Y107 [7,13] in the linker between the N-terminal RS do-
main and RRM1 (Fig. 1, region ‘P’). We have cloned and
expressed three constructs of U2AF65 comprising a truncated
linker lacking the P-rich region followed by the ¢rst RRM
(vP-RRM1, residues 98^237), the linker followed by the ¢rst
RRM (P-RRM1, residues 88^237), and the linker followed by
the ¢rst and the second RRM (P-RRM1+2, residues 88^342).
Pairwise interactions between N-His-tagged U2AF35 RRM
and the di¡erent U2AF65 untagged constructs were probed
using a⁄nity chromatography [17]. As expected, U2AF65 vP-
RRM1 was not able to form a stable heterodimeric complex
with U2AF35 RRM. On the other hand, both U2AF65 P-
RRM1 and P-RRM1+2 were retained on a Ni-NTA a⁄nity
column via interaction with U2AF35 RRM.
Therefore, U2AF65 P-RRM1/U2AF35 RRM and U2AF65
P-RRM1+2/U2AF35 RRM complexes were prepared by co-
puri¢cation of U2AF35 RRM with U2AF65 P-RRM1 and
P-RRM1+2, which were expressed separately as N-His tag
Fig. 2. Biochemical data for the U2AF complexes. A: SDS^polyacrylamide gel electrophoresis of U2AF65 P-RRM1/U2AF35 RRM (lane 1)
and U2AF65 P-RRM1+2/U2AF35 RRM (lane 2) complexes. The abnormal migration of the U2AF35 RRM presumably results from the un-
usual distribution of charged amino acids [27]. B: Gel ¢ltration on a Superdex 75 HiLoad 16/60 of recombinant proteins and complexes: Kav
are plotted as a function of the calculated MW logarithm (log10MW). Kav = (VS3V0)/(VC3V0) where VS, V0 and VC are the sample elution,
void and column volumes, respectively. The depicted selectivity curve (gray line) indicates theoretical Kav values within the fractionation range
of the column. In contrast to U2AF65 P-RRM1 and U2AF65 P-RRM1+2, free or in complex with U2AF35 RRM, the apparent MW of free
U2AF35 RRM is 1.2-fold larger than the theoretical MW (indicated by arrows).
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fusion proteins. After Ni a⁄nity puri¢cation and proteolytic
cleavage of the N-His tag, the U2AF65 fragments were mixed
with puri¢ed N-His-tagged U2AF35 RRM. During gel ¢ltra-
tion single symmetrical peaks are observed indicating homo-
geneity of the two complexes. The elution volumes (Fig. 2B)
are in good agreement with the MWs expected for the hetero-
dimers. The separate expression of U2AF35 and U2AF65
proteins and successive in vitro complex formation allows to
prepare subunit-selective isotopically labelled heterodimers for
NMR studies where this is bene¢cial to reduce spectral over-
lap.
3.5. Induced folding of U2AF35 RRM upon binding to U2AF65
The conformation of U2AF35 RRM when bound to each
of the two U2AF65 fragments comprising the P-rich region
(U2AF65 P-RRM1, P-RRM1+2) was monitored by NMR.
1H,15N HSQC experiments recorded on complexes formed
with 15N-labeled U2AF35 RRM and unlabeled U2AF65
P-RRM1 or U2AF65 P-RRM1+2 clearly show that the
U2AF35 RRM is folded (Fig. 3B). Furthermore, the NMR
spectra of U2AF35 RRM in the two heterodimers are super-
imposable. Thus, the chemical shifts of U2AF35 RRM are
not perturbed by addition of the second RRM of U2AF65
indicating that it does not contact the U2AF35 RRM.
3.6. Contribution of U2AF65 for complex formation with
U2AF35 RRM
We also recorded 1H,15N HSQC experiments on 15N-la-
beled U2AF65 P-RRM1/U2AF35 RRM and 15N-labeled
U2AF65 P-RRM1+2/U2AF35 RRM complexes, which were
only labelled in the U2AF65 subunit. The spectra shown in
Fig. 3C con¢rm that in both complexes the U2AF65 RRM
domains adopt a tertiary structure as expected. The HSQC
spectra also resemble those reported for the separate U2AF65
RRM1 and RRM2 domains [18]. This suggests that there are
no large structural rearrangements involving the U2AF65
RRM1 and RRM2 domains upon binding to U2AF35
RRM. These ¢ndings are consistent with the recently deter-
mined crystal structure of a minimal U2AF heterodimer,
which shows that the P-rich region of U2AF65 is necessary
and su⁄cient to mediate the interaction with U2AF35 RRM
[7]. The crystal structure of a minimal U2AF heterodimer
(U2AF35 RRM/U2AF65 P) revealed that the U2AF35
RRM when bound to the P-rich region of U2AF65 adopts
a canonical RRM-fold comprising a four-stranded anti-paral-
lel L-sheet packed against two K-helices (Fig. 4B). Structure-
based alignment of the U2AF35 RRM sequence with other
RRMs (Fig. 4A) shows that hydrophobic residues that form
the structural core of the RRM fold are all present in
C
Fig. 3. NMR spectra of U2AF complexes. A: Superimposition of
1H,15N HSQC spectra of 15N-labeled U2AF35 RRM free (black)
and when bound to unlabeled U2AF65 P-RRM1 (red) at 295 K. B:
Superimposition of 1H,15N TROSY spectra of U2AF heterodimer
complexes consisting of 15N-labeled U2AF35 RRM bound to
U2AF65 P-RRM1 (black) or U2AF65 P-RRM1+2 (red) at 303 K.
The similarity of the two spectra indicates that the interface of
U2AF35 RRM with U2AF65 is virtually identical in the two com-
plexes. C: 1H,15N TROSY spectra of 15N-labeled U2AF65
P-RRM1/unlabeled U2AF35 RRM (red) and 15N-labeled U2AF65
P-RRM1+2/unlabeled U2AF35 RRM (black) at 295K. Most signals
of the U2AF65 P-RRM1 coincide with corresponding signals in the
larger construct U2AF65 P-RRM1+2 that comprises both RRMs.
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Fig. 4. U2AF35 RRM sequence^structure relationship. A: Structure-based alignment of the U2AF35 RRM sequence (PDB accession number:
1jmt) with sequences of canonical RRMs (1urn: human heterogeneous nuclear ribonucleoprotein A1, 1cvj: human polyadenylate-binding pro-
tein 1, 1ha1: human heterogeneous nuclear ribonucleoprotein A1, 1fht: human U1 small nuclear ribonucleoprotein A, 2u2f: human U2AF65,
2sxl and 1sxl: Drosophila sex lethal protein). The number of the ¢rst residue is given following PDB code. Pairwise comparisons of structures
were performed between U2AF35 RRM and all the other RRMs using DALI server (http://www.ebi.ac.uk/dali/) ; structural similarity is quanti-
¢ed by the Z-score, the root mean square deviation between equivalent atoms and the percentage of sequence identity. Secondary structure ele-
ments are indicated on the top of the alignment. Their precise boundaries in the di¡erent proteins are indicated by bold print. Amino acids col-
ored in yellow are conserved hydrophobic residues that form the structural core. U2AF35 RRM amino acids colored in green are the solvent
accessible hydrophobic and aromatic residues that become buried in the U2AF35 RRM/U2AF65 P complex [7]. B: Ribbon representation of
the U2AF35 RRM/U2AF65 P complex [7]. U2AF35 RRM and U2AF65 P are colored in gray and blue, respectively. Side chains of U2AF35
RRM highlighted in the alignment (yellow, green) as well as side chains of U2AF65 P residues that mediate the U2AF35 RRM interaction
(blue) are displayed.
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U2AF35. However, the U2AF35 RRM fold also exhibits
three distinctive features. First, a 20 amino acid long sequence
insertion in U2AF35 RRM leads to an unusually long pro-
truding helix A, preceded by a disordered loop. Secondly, the
U2AF35 RRM contains numerous negatively charged resi-
dues, many of which are located in this elongated helix A.
Thirdly, the U2AF35 RRM exhibits a solvent-exposed hydro-
phobic patch (including F81, W134, F135 and P139) which
mediates the U2AF65 interaction. In total, 26% of the solvent
accessible surface of U2AF35 RRM is buried in the U2AF
minimal complex [7] such that the heterodimer interface may
be considered as an additional intermolecular hydrophobic
core. These sequence characteristics of the U2AF35 RRM
may thus play a role for our ¢nding that the recombinant
free U2AF35 RRM is unstructured in solution. Alternatively,
it is also possible that the Zn knuckles £anking the RRM
domain N- and C-terminally in the U2AF35 FL protein con-
tribute to stabilizing the tertiary structure of the RRM do-
main even in the absence of the U2AF65 ligand. Further
experiments are required to distinguish between these possi-
bilities. In any case, folding of the U2AF35 RRM as shown in
the NMR spectra is likely induced upon binding to the
U2AF65 P-rich region. This is demonstrated by the crystal
structure of the U2AF35 RRM bound to the P-rich region
of U2AF65 and further supported by the similarity of NMR
spectra of the U2AF65 RRMs free and bound to U2AF35
RRM (see above). Therefore, it appears that di¡erent regions
of U2AF65 are used in a modular way to mediate contacts
with U2AF35 (the P-rich region) and the pre-mRNA
(RRM1+2), respectively [19].
4. Conclusion
It is well known that an unstructured protein may undergo
an induced transition from random coil to a well-de¢ned con-
formation upon interaction with a binding partner which may
be a nucleic acid [20,21] or a protein [22^24]. Two unstruc-
tured domains can also mutually act as chaperones towards
each other [25,26]. In the present paper, we found that the
monomeric free form of U2AF35 RRM is unstructured in
solution and that its three-dimensional structure is induced
upon binding to its native protein partner U2AF65.
The characterization of the U2AF35 RRM when bound to
di¡erent regions of U2AF65 is a prerequisite for future struc-
tural and functional studies of the U2AF heterodimer and
its interaction with the pre-mRNA during spliceosome assem-
bly. Supplementary material (U2AF35 sequence alignment)
can be found on the web at http://www.elsevier.com/PII/
S0014579302032945.
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